Kidney function and systolic blood pressure new insights from cystatin C: Data from the Heart and Soul Study

被引:39
|
作者
Peralta, Carmen A.
Whooley, Mary A.
Ix, Joachim H.
Shlipak, Michael G.
机构
[1] Va Med CXtr, Gen Internal Med Sect, San Francisco, CA 94124 USA
[2] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
关键词
kidney; hypertension; cystatin C; systolic blood pressure;
D O I
10.1016/j.amjhyper.2006.02.007
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Control of hypertension is paramount in treating chronic kidney disease. The relationship between kidney function and blood pressure (BP) components has been studied in persons with diagnosed CKD, diabetes, or hypertension. Whether kidney function in the normal range is associated with systolic BP (SBP), diastolic BP (DBP), and pulse pressure is unclear. Methods: We evaluated the association between kidney function and each BP component using cystatin C and 24-h creatinine clearance (CrCl) among 906 participants in the Heart and Soul Study. Results: We observed that SBP was linearly associated with cystatin C concentrations (1.19 +/- 0.55 mm Hg increase per 0.4 mg/L cystatin C, P = .03) across the range of kidney functions. In contrast, using CrCl, SBP was significantly associated with kidney function only in subjects with CrCl < 60 mL/min (6.4 +/- 2.13 mm Hg increase per 28 mL/min, P = .003) but not > 60 mL/min (0.36 +/- 0.77 mm Hg per 28 mL/min, P = .64). Slopes differed significantly (for spline term P = .001). We found that DBP was not associated with cystatin C (0.34 +/- 0.40 mm Hg per 0.4 mg/L cystatin, P = .39) or CrCl (0.62 +/- 0.44 mm Hg per 28 mL/min clearance, P = .16). Pulse pressure was linearly associated with cystatin C (1.28 +/- 0.55 mm Hg per 0.4 mg/L cystatin, P = .02) and with CrCl < 60 mL/min (7.27 +/- 2.16 mm Hg per 28 mL/min, P = .001). Conclusions: Both SBP and pulse pressure were significantly associated with kidney function across a wide range of cystatin C concentrations, even in subjects with presumably normal kidney function, by creatinine-based measures. Cystatin C may provide new insights into the association of CKD and hypertension, a relationship that may be an underappreciated barrier to hypertension control.
引用
收藏
页码:939 / 946
页数:8
相关论文
共 50 条
  • [41] Blood Pressure, Sexual Activity, and Erectile Function in Hypertensive Men: Baseline Findings from the Systolic Blood Pressure Intervention Trial (SPRINT)
    Foy, Capri G.
    Newman, Jill C.
    Berlowitz, Dan R.
    Russell, Laurie P.
    Kimmel, Paul L.
    Wadley, Virginia G.
    Thomas, Holly N.
    Lerner, Alan J.
    Riley, William T.
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (02) : 235 - 247
  • [42] Hypotensive Episodes on 24-Hour Ambulatory Blood Pressure and Cognitive Function: Insights From the SPRINT Study
    Zhang, Wenxin
    Redline, Susan
    Viswanathan, Anand
    Ascher, Simon B.
    Hari, Darshana
    Juraschek, Stephen P.
    Tzourio, Christophe
    Drawz, Paul E.
    Lipsitz, Lewis A.
    Mittleman, Murray A.
    Ma, Yuan
    HYPERTENSION, 2025, 82 (04) : 627 - 637
  • [43] Usefulness of Combined Risk Stratification With Heart Rate and Systolic Blood Pressure in the Management of Chronic Heart Failure - A Report From the CHART-2 Study
    Miura, Masanobu
    Sakata, Yasuhiko
    Miyata, Satoshi
    Nochioka, Kotaro
    Takada, Tsuyoshi
    Tadaki, Soichiro
    Takahashi, Jun
    Shiba, Nobuyuki
    Shimokawa, Hiroaki
    CIRCULATION JOURNAL, 2013, 77 (12) : 2954 - 2962
  • [44] Orthostatic Blood Pressure Changes and Cognitive Function: Insights From the SPRINT MIND Trial
    Yang, Ruixue
    Cai, Jun
    CIRCULATION, 2023, 148
  • [45] Unstably controlled systolic blood pressure trajectories are associated with markers for kidney damage in prediabetic population: results from the INDEED cohort study
    Sun, Zi-Jun
    Wang, Jin-Wei
    Chang, Dong-Yuan
    Chen, Shuo-Hua
    Zhang, Hui-Fen
    Wu, Shou-Ling
    He, Kevin
    Zhang, Lu-Xia
    Chen, Min
    Zhao, Ming-Hui
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [46] Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program
    Ildiko Lingvay
    Ofri Mosenzon
    Katelyn Brown
    Xuewei Cui
    Ciara O’Neill
    Laura Fernández Landó
    Hiren Patel
    Cardiovascular Diabetology, 22
  • [47] Differential sex effects of systolic blood pressure and low-density lipoprotein cholesterol on type 2 diabetes: Life course data from the Bogalusa Heart Study
    Pollock, Benjamin D.
    Chen, Wei
    Harville, Emily W.
    Shu, Tian
    Fonseca, Vivian
    Mauvais-Jarvis, Franck
    Kelly, Tanika N.
    Bazzano, Lydia A.
    JOURNAL OF DIABETES, 2018, 10 (06) : 449 - 457
  • [48] An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study
    He, William J.
    Li, Changwei
    Mi, Xuenan
    Shi, Mengyao
    Gu, Xiaoying
    Bazzano, Lydia A.
    Razavi, Alexander C.
    Nierenberg, Jovia L.
    Dorans, Kirsten
    He, Hua
    Kelly, Tanika N.
    JOURNAL OF HYPERTENSION, 2020, 38 (07) : 1302 - 1311
  • [49] Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study
    Wang, Zhiyan
    Li, Wenjie
    Jiang, Chao
    Wang, Jue
    Hua, Chang
    Tang, Yangyang
    Zhang, Hao
    Liu, Xinru
    Wang, Yufeng
    Gao, Mingyang
    Lv, Qiang
    Dong, Jianzeng
    Ma, Changsheng
    Du, Xin
    JOURNAL OF HYPERTENSION, 2024, 42 (07) : 1203 - 1211
  • [50] Relationship between the lower limit of systolic blood pressure target and kidney function decline in advanced chronic kidney disease: an instrumental variable analysis from the REACH-J CKD cohort study
    Kurasawa, Shimon
    Yasuda, Yoshinari
    Kato, Sawako
    Maruyama, Shoichi
    Okada, Hirokazu
    Kashihara, Naoki
    Narita, Ichiei
    Wada, Takashi
    Yamagata, Kunihiro
    HYPERTENSION RESEARCH, 2023, 46 (11) : 2478 - 2487